Feline Lymphoma: Welfare Through Diagnosis and Treatment Choices
Feline lymphoma is the most common cat cancer — treatment options range from palliative to curative depending on location, and welfare guides all decisions.
Key Facts
- Lymphoma accounts for approximately 30% of all feline cancers
- Alimentary (gastrointestinal) lymphoma is most common in older cats; mediastinal in younger cats
- Small cell lymphoma responds well to chlorambucil and has long median survival of 2+ years
- Large cell lymphoma has poorer prognosis despite multi-agent chemotherapy
- Early treatment decision discussions with a veterinary oncologist maximize welfare options
Welfare Considerations
Feline lymphoma welfare decisions hinge on the type, stage, and location of disease. Small cell alimentary lymphoma — the most common form in older cats — is a success story in feline oncology: oral chlorambucil tablets given every other day, combined with prednisolone, achieves median survival times of 2+ years with excellent quality of life during treatment. Cats often maintain appetite, activity, and social behavior during treatment. Large cell lymphoma carries a worse prognosis even with intensive multi-drug protocols, but meaningful survival extension with good quality of life remains achievable. Welfare assessment throughout treatment — monitoring appetite, weight, activity, and behavior — should guide continuation, modification, or stopping of treatment. Palliative prednisolone is a valid welfare choice when curative intent is not pursued.
What You Can Do
- Consult a veterinary oncologist or internal medicine specialist for lymphoma staging and treatment planning
- For small cell GI lymphoma, commit to the chlorambucil protocol — results are excellent and cat quality of life maintained
- Monitor weight, appetite, and litter box behavior weekly as welfare indicators
- Treat concurrent conditions including IBD and B12 deficiency for optimal quality of life
- Plan end-of-life care proactively — having a quality of life framework guides compassionate timing decisions